These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 17610876)

  • 1. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid.
    Van Antwerpen P; Dufrasne F; Lequeux M; Boudjeltia KZ; Lessgyer I; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
    Eur J Pharmacol; 2007 Sep; 570(1-3):235-43. PubMed ID: 17610876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
    Van Antwerpen P; Legssyer I; Zouaoui Boudjeltia K; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
    Eur J Pharmacol; 2006 May; 537(1-3):31-6. PubMed ID: 16631159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification.
    Van Antwerpen P; Prévost M; Zouaoui-Boudjeltia K; Babar S; Legssyer I; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J; Dufrasne F
    Bioorg Med Chem; 2008 Feb; 16(4):1702-20. PubMed ID: 18063373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme.
    Van Antwerpen P; Moreau P; Zouaoui Boudjeltia K; Babar S; Dufrasne F; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
    Talanta; 2008 Apr; 75(2):503-10. PubMed ID: 18371913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The free amino acid tyrosine enhances the chlorinating activity of human myeloperoxidase.
    Vlasova II; Sokolov AV; Arnhold J
    J Inorg Biochem; 2012 Jan; 106(1):76-83. PubMed ID: 22112843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design.
    Jantschko W; Furtmüller PG; Zederbauer M; Neugschwandtner K; Lehner I; Jakopitsch C; Arnhold J; Obinger C
    Biochem Pharmacol; 2005 Apr; 69(8):1149-57. PubMed ID: 15794935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of products formed by reaction of 3',5'-di-O-acetyl-2'-deoxyguanosine with hypochlorous acid or a myeloperoxidase-H2O2-Cl- system.
    Suzuki T; Friesen MD; Ohshima H
    Chem Res Toxicol; 2003 Mar; 16(3):382-9. PubMed ID: 12641439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil- and myeloperoxidase-mediated metabolism of reduced nimesulide: evidence for bioactivation.
    Yang M; Chordia MD; Li F; Huang T; Linden J; Macdonald TL
    Chem Res Toxicol; 2010 Nov; 23(11):1691-700. PubMed ID: 20939553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiol-containing molecules interact with the myeloperoxidase/H2O2/chloride system to inhibit LDL oxidation.
    Van Antwerpen P; Boudjeltia KZ; Babar S; Legssyer I; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
    Biochem Biophys Res Commun; 2005 Nov; 337(1):82-8. PubMed ID: 16171780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs investigated with a human recombinant enzyme.
    Nève J; Parij N; Moguilevsky N
    Eur J Pharmacol; 2001 Apr; 417(1-2):37-43. PubMed ID: 11301057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system. A possible correlation with their anti-inflammatory properties.
    van Zyl JM; Basson K; Kriegler A; van der Walt BJ
    Biochem Pharmacol; 1991 Jul; 42(3):599-608. PubMed ID: 1650217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase-catalyzed taurine chlorination: initial versus equilibrium rate.
    Ramos DR; Victoria García M; Canle L M; Arturo Santaballa J; Furtmüller PG; Obinger C
    Arch Biochem Biophys; 2007 Oct; 466(2):221-33. PubMed ID: 17868637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH as a co-substrate for studies of the chlorinating activity of myeloperoxidase.
    Auchère F; Capeillère-Blandin C
    Biochem J; 1999 Nov; 343 Pt 3(Pt 3):603-13. PubMed ID: 10527939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid.
    Allegra M; Furtmüller PG; Jantschko W; Zederbauer M; Tesoriere L; Livrea MA; Obinger C
    Biochem Biophys Res Commun; 2005 Jul; 332(3):837-44. PubMed ID: 15913556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlorination of N-acetyltyrosine with HOCl, chloramines, and myeloperoxidase-hydrogen peroxide-chloride system.
    Drabik G; Naskalski JW
    Acta Biochim Pol; 2001; 48(1):271-5. PubMed ID: 11440179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the chlorinating activity of myeloperoxidase by tempol: revisiting the kinetics and mechanisms.
    Queiroz RF; Vaz SM; Augusto O
    Biochem J; 2011 Nov; 439(3):423-31. PubMed ID: 21749327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the myeloperoxidase-H2O2-Cl- system of neutrophils by indomethacin and other non-steroidal anti-inflammatory drugs.
    Shacter E; Lopez RL; Pati S
    Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):975-84. PubMed ID: 1848981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of cholesterol ozonolysis products through an ozone-free mechanism mediated by the myeloperoxidase-H2O2-chloride system.
    Tomono S; Miyoshi N; Sato K; Ohba Y; Ohshima H
    Biochem Biophys Res Commun; 2009 May; 383(2):222-7. PubMed ID: 19345674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations.
    Koelsch M; Mallak R; Graham GG; Kajer T; Milligan MK; Nguyen LQ; Newsham DW; Keh JS; Kettle AJ; Scott KF; Ziegler JB; Pattison DI; Fu S; Hawkins CL; Rees MD; Davies MJ
    Biochem Pharmacol; 2010 Apr; 79(8):1156-64. PubMed ID: 19968966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols.
    Hazen SL; Hsu FF; Duffin K; Heinecke JW
    J Biol Chem; 1996 Sep; 271(38):23080-8. PubMed ID: 8798498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.